The San Diego, Calif.-based company expects that its device will be able to display both English and French and will include a 24-hour clock.
“This application is another important step toward achieving our strategic goal of bringing the benefits of the t:slim X2 Insulin Pump to people outside of the United States,” president & CEO Kim Blickenstaff said in prepared remarks.
“When available, the t:slim X2 will provide people in Canada a competitive choice in the durable insulin pump market, which we believe will be of particular interest as the only pump with Dexcom G5 Mobile CGM integration.”
Last week, Tandem inked its first distribution agreement outside the U.S. for its insulin delivery device. In partnership with Rubin Medical, the company plans to commercialize its t:slim X2 insulin pump, insulin cartridges and t:lock infusion sets in Sweden, Norway and Denmark.
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.